Dublin, Dec. 09, 2020 (GLOBE NEWSWIRE) -- The "Asia-Pacific Animal Health Market - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The APAC Animal Health Market is Projected to Reach a Value of USD 22.1 Billion by 2025 from USD 15.6 Billion in 2020, at a CAGR of 7.2% during the Forecast Period.
In this report, the APAC animal health market is segmented based on product type, animal type, end-user, and geography. Factors such as the rapid rise in livestock population, increasing awareness about animal health, and the rising frequency of animal disease outbreaks are expected to drive the growth of the APAC animal health market.
However, restrictions on the use of parasiticides in food-producing animals, shift toward vegetarian diets, and the rising cost of storage of animal vaccines are expected to restrain the growth of this market.
Emerging markets such as China and India and growing companion animal ownership and adoption of pet insurance offer significant growth opportunities in the APAC animal health market. Diversity of parasites and growing resistance (in parasites) to parasiticides and antibiotics are major challenges for this industry.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 APAC Animal Health Market Overview
4.2 Asia-Pacific: Animal Health Market, by Product Type and End-User (2019)
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Demand for Animal-Derived Food Products
5.2.1.2 Increasing Livestock Population and Growing Awareness About Animal Health
5.2.1.3 Growing Frequency of Animal Disease Outbreaks
5.2.2 Restraints
5.2.2.1 Restrictions on Use of Parasiticides in Food-Producing Animals
5.2.2.2 Shift Toward Vegetarian Diet
5.2.2.3 Rising Vaccine Storage Cost
5.2.3 Opportunities
5.2.3.1 Lucrative Growth Opportunities in India and China
5.2.3.2 Growth in Companion Animal Ownership and Rising Adoption of Pet Health Insurance
5.2.4 Challenges
5.2.4.1 Growing Resistance to Parasiticides and Antibiotics
5.2.4.2 Diversity of Parasite Species
5.2.4.3 Inadequate Surveillance and Reporting Systems of Vaccines
5.2.4.4 High Costs of Feed Additive Leading to Adoption of Conventional Feeding Systems
5.2.5 Industry Trends
5.2.5.1 Innovations in Animal Healthcare Products
5.2.5.2 Consolidation in Animal Health Industry
5.3 COVID-19 Health Assessment
6 APAC Animal Health Market, by Product
6.1 Introduction
6.2 Growth Promoters
6.3 Feed Additives/Nutritional Products
6.4 Vaccines
6.5 Parasiticides
6.6 Antimicrobials & Antibiotics
6.7 Other Pharmaceuticals
7 APAC Animal Health Market, by Animal
7.1 Introduction
7.2 Food Producing Animals
7.3 Companion Animals
8 APAC Animal Health Market, by End-User
8.1 Introduction
8.2 Animal Farms
8.3 Veterinary Hospitals & Clinics
8.4 Homecare
9 APAC Animal Health Market, by Country
10 Competitive Landscape
11 Startup Matrix
12 Company Profiles
- Ashish Life Science (Als)
- Boehringer Ingelheim
- Bovicure Pharma
- Ceva Sante Animale
- China Animal Husbandry
- Dechra Pharmaceuticals plc.
- Elanco Animal Health
- Endovac Animal Health
- Hipra
- Indian Immunologicals Ltd.
- Jinyu Bio-Technology
- Kyoritsu Seiyako
- Lutim Pharma
- Merck Animal Health
- Phibro Animal Health
- Tianjin Ringpu
- Vetoquinol S.A.
- Virbac
- Zoetis Inc.
- Zydus Animal Health
For more information about this report visit https://www.researchandmarkets.com/r/vw0qhp
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.